Xiqiang Cheng

Identification of spirocyclic or phosphate substituted quinolizine derivatives as novel HIV-1 integrase inhibitors: a patent evaluation of WO2016094197A1, WO2016094198A1 and WO2016154527A1

P. Zhan, Xinyong Liu, Lin Sun, 2017, Expert opinion on therapeutic patents.

Design, synthesis, and biologic evaluation of novel galloyl derivatives as HIV‐1 RNase H inhibitors

Peng Zhan, Jacob Kongsted, Luis Menéndez-Arias, 2019, Chemical biology & drug design.

5-Hydroxypyrido[2,3-b]pyrazin-6(5H)-one derivatives as novel dual inhibitors of HIV-1 reverse transcriptase-associated ribonuclease H and integrase.

Peng Zhan, Xiao Ding, Luis Menéndez-Arias, 2018, European journal of medicinal chemistry.

Design, synthesis and biological evaluation of 3-hydroxyquinazoline-2,4(1H,3H)-diones as dual inhibitors of HIV-1 reverse transcriptase-associated RNase H and integrase.

E. De Clercq, C. Pannecouque, P. Zhan, 2019, Bioorganic & medicinal chemistry.

Novel RNase H inhibitors blocking RNA-directed strand displacement DNA synthesis by HIV-1 reverse transcriptase.

Dongwei Kang, P. Zhan, Xinyong Liu, 2022, Journal of molecular biology.